Evidence map›Paper›PMID 31790972›Full record

ArticleMolecular therapy. Nucleic acids2020

miR-140 Attenuates the Progression of Early-Stage Osteoarthritis by Retarding Chondrocyte Senescence.

Hai-Bo Si, Ti-Min Yang, Lan Li, Mei Tian, Li Zhou, Dai-Ping Li, Qiang Huang, Peng-de Kang, Jing Yang, Zong-Ke Zhou and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecular therapy. Nucleic acids, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed, 1 pooled it
8.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Hai-Bo SiDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China; Key Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.
Ti-Min YangDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China; Department of Orthopaedics, Tibet Autonomous Region People's Hospital, Lasa 850000, China.
Lan LiKey Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.
Mei TianDepartment of Ultrasound, West China Hospital, Sichuan University, Chengdu 610041, China.
Li ZhouResearch Core Facility, West China Hospital, Sichuan University, Chengdu 610041, China.
Dai-Ping LiDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Qiang HuangDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Peng-de KangDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Jing YangDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Zong-Ke ZhouDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China.
Jing-Qiu ChengKey Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, Chengdu 610041, China.
Bin ShenDepartment of Orthopaedics and National Clinical Research Centre for Geriatrics, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: shenbin_1971@163.com.
Sichuan University · CNWest China Hospital of Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Osteoarthritis (OA) is a major cause of joint pain and disability, and chondrocyte senescence is a key pathological process in OA and may be a target of new therapeutics. MicroRNA-140 (miR-140) plays a protective role in OA, but little is known about its epigenetic effect on chondrocyte senescence. In this study, we first validated the features of chondrocyte senescence characterized by increased cell cycle arrest in the G0/G1 phase and the expression of senescence-associated β-galactosidase (SA-βGal), p16

Identifiers

PMID31790972
PMCPMC6909049
OpenAlexW2986447197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.